Live from the NIH registry
Studies recruiting near Worcester right now
Top 25 of 273 recruiting studies, sorted by proximity — each links to its official registry page
Targeting Nociceptors in Hidradenitis Suppurativa
Hidradenitis Suppurativa, Hyperhidrosis
N/A
Observational 20 participants sought
University of Massachusetts Chan Medical School — Worcester, Massachusetts (0.6 mi)
· Sponsor: University of Massachusetts, Worcester
A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting
Pneumonia
N/A
Observational 12,500 participants sought
UMass Memorial Medical Center — Worcester, Massachusetts (0.6 mi)
· Sponsor: Pfizer
Lupus Landmark Study: A Prospective Registry and Biorepository
Systemic Lupus Erythematosus (SLE), Lupus Nephritis
N/A
Observational 3,500 participants sought
University of Massachusetts Memorial Health — Worcester, Massachusetts (0.6 mi)
· Sponsor: Lupus Research Alliance
Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type
Agitation
Phase 2
Interventional 150 participants sought
Vitalix — Worcester, Massachusetts (0.6 mi)
· Sponsor: Teikoku Pharma USA, Inc.
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Relapsing Multiple Sclerosis, Multiple Sclerosis
N/A
Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Norfolk, Massachusetts (26.8 mi)
· Sponsor: TG Therapeutics, Inc.
Re-Engineered Discharge for Diabetes Care Transitions
Diabetes Mellitus Type 2, Social Determinants of Health (SDOH)
N/A
Interventional 412 participants sought
UMASS Memorial Healthcare System — Worcester, Massachusetts (0.6 mi)
· Sponsor: University of Massachusetts, Worcester
Individualizing Treatment for Asthma in Primary Care (Full Study)
Asthma, Asthma Attack
Phase 4
Interventional 3,200 participants sought
Reliant Medical Group — Worcester, Massachusetts (0.6 mi)
· Sponsor: DARTNet Institute
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
UMass Memorial Medical Center - University Campus — Worcester, Massachusetts (0.6 mi)
· Sponsor: SWOG Cancer Research Network
SELUTION4BTK Trial
Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia Nos of Native Arteries of Extremities
N/A
Interventional 376 participants sought
University of Massachusetts Medical Center — Worcester, Massachusetts (0.6 mi)
· Sponsor: M.A. Med Alliance S.A.
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8
Phase 3
Interventional 1,500 participants sought
Dana-Farber/Brigham and Women's Cancer Center at Milford Regional — Milford, Massachusetts (17.4 mi)
· Sponsor: NRG Oncology
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
Immune Thrombocytopenic Purpura (ITP)
Phase 3
Interventional 150 participants sought
University of Massachusetts Chan Medical School — Worcester, Massachusetts (0.6 mi)
· Sponsor: Takeda
A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
COVID-19 Infection
Phase 3
Interventional 300 participants sought
University of Massachusetts Chan Medical School — Worcester, Massachusetts (0.6 mi)
· Sponsor: Pfizer
Improving Jail Response to the Overdose Crisis: A Hybrid Trial of Jail ECHO to Improve MOUD Implementation and Public Health Outcomes
Opioid Abuse (Disorder)
N/A
Interventional 100 participants sought
UMass Chan Medical School — Worcester, Massachusetts (0.6 mi)
· Sponsor: University of Massachusetts, Worcester
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
Renal Pelvis and Ureter Urothelial Carcinoma
Phase 2, Phase 3
Interventional 131 participants sought
UMass Memorial Medical Center - University Campus — Worcester, Massachusetts (0.6 mi)
· Sponsor: National Cancer Institute (NCI)
Nectero EAST System Clinical Study
Abdominal Aortic Aneurysm
Phase 2, Phase 3
Interventional 400 participants sought
University of Massachusetts — Worcester, Massachusetts (0.6 mi)
· Sponsor: Nectero Medical, Inc.
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II)
Lower Extremity Acute Limb Ischemia, LE ALI
N/A
Observational 300 participants sought
UMass Memorial Medical Center — Worcester, Massachusetts (0.6 mi)
· Sponsor: Penumbra Inc.
A Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adults With New-onset Generalized Myasthenia Gravis (gMG)
New Onset Generalized Myasthenia Gravis (gMG)
Phase 4
Interventional 30 participants sought
UMass Memorial Medical Center — Worcester, Massachusetts (0.6 mi)
· Sponsor: argenx
ELEVATE High-Risk PCI Pivotal Study
High-Risk Percutaneous Coronary Intervention (High-risk PCI)
N/A
Interventional 290 participants sought
UMass Memorial Medical Center — Worcester, Massachusetts (0.6 mi)
· Sponsor: Magenta Medical Ltd.
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
ADHD
Phase 3
Interventional 468 participants sought
Clinical Research Site — Worcester, Massachusetts (0.6 mi)
· Sponsor: Axsome Therapeutics, Inc.
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)
Non-small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 614 participants sought
University of Massachusetts Chan Medical School-Division of Hematology/Oncology ( Site 0144) — Worcester, Massachusetts (0.6 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
Phase 3
Interventional 1,800 participants sought
89bio Clinical Study Site — Framingham, Massachusetts (20.0 mi)
· Sponsor: Hoffmann-La Roche
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8
Phase 2
Interventional 474 participants sought
Dana-Farber/Brigham and Women's Cancer Center at Milford Regional — Milford, Massachusetts (17.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Androgen-responsive POSLUMA-guided Intra-prostatic Boost
Intermediate Risk Prostate Cancer, High Risk Prostate Cancer
Phase 2
Interventional 23 participants sought
Dana-Farber/Brigham and Women's Cancer Center at Milford Regional Medical Center — Milford, Massachusetts (17.4 mi)
· Sponsor: Martin T. King, MD, PhD
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
Hepatitis
Phase 3
Interventional 350 participants sought
UMass Chan Medical School — Worcester, Massachusetts (0.6 mi)
· Sponsor: Bausch Health Americas, Inc.
A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
Colitis, Ulcerative
Phase 2, Phase 3
Interventional 120 participants sought
University of Massachusetts Chan Medical School — Worcester, Massachusetts (0.6 mi)
· Sponsor: Bristol-Myers Squibb